Roadblock on the recycling route : development of novel autophagy inhibitors
Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Department of Pharmaceutical Sciences,283 p.
Phenotypic and target-based approach to antitubercular drug discovery : investigation of thienopyrimidine and hydantoin scaffolds as new hits against Mycobacterium tuberculosis
Source
Antwerp, University of Antwerp, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Department of Pharmaceutical Sciences,iii, 334 p.
Vectorized ULK1/2 and VPS34 inhibitors for tissue-selective autophagy inhibition in oncology
Source
Journal of medicinal chemistry - ISSN 0022-2623-69:3 (2026) p. 2041-2062
Selective and orally bioavailable dipeptidyl peptidase 9 inhibitors with potent pyroptosis induction properties
Source
Journal of medicinal chemistry - ISSN 0022-2623-68:21 (2025) p. 23163-23184
Using protease inhibitors to prevent intraperitoneal adhesions : effects of nafamostat mesylate, UAMC-00050, GM6001, and enoxaparin in the cecal ligation and puncture model and the ischemic button model
Source
Surgery today - ISSN 0941-1291- (2025) p.